Sargent Bickham Lagudis’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-200
| Closed | -$4K | – | 796 |
|
|
2020
Q2 | $4K | Sell |
200
-358
| -64% | -$7.16K | ﹤0.01% | 658 |
|
|
2020
Q1 | $6K | Buy |
558
+200
| +56% | +$2.15K | ﹤0.01% | 618 |
|
|
2019
Q4 | $13K | Sell |
358
-371
| -51% | -$13.5K | ﹤0.01% | 577 |
|
|
2019
Q3 | $34K | Sell |
729
-1,535
| -68% | -$71.6K | ﹤0.01% | 393 |
|
|
2019
Q2 | $118K | Hold |
2,264
| – | – | 0.01% | 260 |
|
|
2019
Q1 | $156K | Sell |
2,264
-52
| -2% | -$3.58K | 0.02% | 238 |
|
|
2018
Q4 | $138K | Hold |
2,316
| – | – | 0.02% | 235 |
|
|
2018
Q3 | $268K | Hold |
2,316
| – | – | 0.03% | 183 |
|
|
2018
Q2 | $292K | Hold |
2,316
| – | – | 0.04% | 166 |
|
|
2018
Q1 | $251K | Hold |
2,316
| – | – | 0.03% | 181 |
|
|
2017
Q4 | $254K | Hold |
2,316
| – | – | 0.03% | 192 |
|
|
2017
Q3 | $229K | Hold |
2,316
| – | – | 0.03% | 203 |
|
|
2017
Q2 | $235K | Hold |
2,316
| – | – | 0.03% | 193 |
|
|
2017
Q1 | $268K | Hold |
2,316
| – | – | 0.03% | 182 |
|
|
2016
Q4 | $278K | Hold |
2,316
| – | – | 0.04% | 169 |
|
|
2016
Q3 | $260 | Sell |
2,316
-153
| -6% | -$17 | 0.04% | 182 |
|
|
2016
Q2 | $306K | Hold |
2,469
| – | – | 0.05% | 163 |
|
|
2016
Q1 | $278K | Buy |
+2,469
| New | +$278K | 0.04% | 173 |
|